Emerging modalities such as self-amplifying and circular RNA, expanding oncology and rare-disease applications, and scalable manufacturing are creating high-growth investment avenues, supported by ...

MILFORD, Mass., Oct. 10, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify ...

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Flu RNA Vaccines Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

New research shows that lipid nanoparticles used in mRNA vaccines may deliver RNA more effectively when their structure is disorganised.

RNA therapeutics have been around since the late 1990s, but interest in these medicines has skyrocketed since the outbreak of the coronavirus pandemic and the success of messenger RNA (mRNA) vaccines.

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Enesi Pharma, an innovative biotechnology company, announced its collaboration with Prof. Robin Shattock, a leading infectious disease and vaccine expert, and his group at Imperial College London ...

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine. But as ...

Researchers developed C28, an engineered polymerase that efficiently synthesizes RNA at near-natural speeds with high accuracy. Created through directed evolution, the enzyme also performs reverse ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents—and they've shown a possible ...